CVAid Medical, a Tel Aviv, Israel-based digital health company that developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), has announced the completion of the capital raising from Philips together with Sanara Capital.
The Israeli Rad Biomed investment fund led the capital raising. This is the company's first round of funding (Round A), totaling $4 million.
Company: CVAid Medical
Raised: $4.0M
Round: unknown
Funding Month: February 2022
Lead Investors: Rad Biomed investment fund
Additional Investors: Philips and Sanara Capital
Company Website: https://www.cvaidmedical.com/
Software Category: AI-based stroke triage technological platform
About the Company: CVAid was established in 2018 by a group of entrepreneurs who combine business, tech, and medical expertise, including the company's CEO, Oren Dror, and Danny Farin. CVAid developed a platform based on artificial intelligence for diagnosing and treating cerebrovascular accidents (CVAs, or strokes), CVAid's platform also allows non-professional staff, such as in retirement homes, nursing homes, or family members, to film the patient when there is fear of a stroke - and in the event of a positive diagnosis, to perform a rapid evacuation process and put the medical staff on alert. This enables remote diagnosis, control, and management of patients suspected of suffering a stroke at a very early stage, and coordination of the evacuation and transfer of the patient to the appropriate medical center, as well as preparing and readying the medical staff in advance immediately upon arrival of the ambulance to the hospital. CVAid is aiming to improve stroke triage and spread our advanced technologies to save the lives of people around the globe.
Source: https://www.prnewswire.com/il/news-releases/the-israeli-start-up-cvaid-raises-4-million-including-investment-by-philips-for-its-ai-based-platform-for-diagnosis-of-stroke-301491371.html